Immediate protein expression from exogenous mRNAs in embryonic brain.

Area of Science:

• Neuroscience
• Molecular Biology
• Biotechnology

Background:

• Messenger RNA (mRNA) vaccines have demonstrated significant success in combating SARS-CoV-2.
• The efficiency of protein production from exogenous mRNA in the developing brain remains largely uncharacterized.

Purpose of the Study:

• To investigate the efficiency and kinetics of protein expression from exogenous mRNA in embryonic neural stem cells.
• To compare mRNA delivery with plasmid transfection for protein expression in the embryonic mouse brain.

Main Methods:

• Electroporation of mRNA and plasmids into the embryonic mouse brain.
• Detection and quantification of protein expression at various time points post-delivery.

Main Results:

• Highly efficient protein expression was observed in neural stem cells following mRNA electroporation.
• Protein expression from mRNA was detected as early as 1 hour post-electroporation.
• Plasmid transfection showed detectable protein expression at 12 hours post-electroporation, indicating faster kinetics for mRNA.

Conclusions:

• Exogenous mRNA enables rapid and efficient protein production in embryonic neural stem cells.
• mRNA delivery presents a promising tool for functional analysis and potential therapeutic interventions in the brain.
• The temporal efficiency of mRNA highlights its potential utility beyond vaccination strategies.